Matthew J. Price

Showing 1-2 of 2 articles

The functional assessment of patients with non-obstructive coronary artery disease: expert review from an international microcirculation working group

Widmer RJ, Samuels B, Samady H, Price M, Jeremias A, Anderson RD, Jaffer F, Escaned J, Davies J, Prasad M, Grines C, Lerman A

March 20, 2019 | 10.4244/EIJ-D-18-00982

Short- and long-term mortality following bleeding events in patients undergoing percutaneous coronary intervention: insights from four validated bleeding scales in the CHAMPION trials

Vaduganathan M, Harrington R, Stone G, Steg P, Gibson M, Hamm C, Price M, Lopes R, Leonardi S, Deliargyris E, Prats J, Mahaffey K, White H, Bhatt D

February 2, 2018 | 10.4244/EIJ-D-17-00723

1

Latest news

CTOs, next-day discharge after TAVI, ViV, cerebral embolic protection, TMVR

Ahead of Print: Transcatheter mitral replacement after AVR

August 13, 2020

"Minimalist” TAVI during the COVID-19 pandemic: previously optional but now a necessity

August 13, 2020

Guidance Papers

Guidelines, consensus & position papers

TWILIGHT, ONYX ONE, DKCRUSH-V and much more

(The Trials book is supported by Biotronik)

August 11, 2020

IVUS for guidance of coronary interventions: applying optimisation targets to improve clinical outcomes

August 13, 2020

This Week's JAA's: Real-world Use of the Evolut PRO Valve...

Valvular disease